Loading...
A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcom a of the uterus, an NRG Oncology/Gynecologic Oncology Group study()
BACKGROUND: The primary objectives were to determine the objective response rate (ORR) and safety profile of ixabepilone in women with recurrent or persistent uterine carcinosarcoma (UCS). Secondary objectives included progression-free survival (PFS) and overall survival (OS). Exploratory translatio...
Na minha lista:
| Udgivet i: | Gynecol Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362250/ https://ncbi.nlm.nih.gov/pubmed/28029447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.10.026 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|